Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

136 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Results of an early safety analysis of a study of the combination of pembrolizumab and pelvic chemoradiation in locally advanced cervical cancer.
Duska LR, Scalici JM, Temkin SM, Schwarz JK, Crane EK, Moxley KM, Hamilton CA, Wethington SL, Petroni GR, Varhegyi NE, Clift SH, Bullock TNJ, Showalter TN. Duska LR, et al. Among authors: petroni gr. Cancer. 2020 Nov 15;126(22):4948-4956. doi: 10.1002/cncr.33136. Epub 2020 Sep 10. Cancer. 2020. PMID: 32910478 Free article. Clinical Trial.
Sequential chemotherapy (etoposide, vinblastine, and doxorubicin) and subtotal lymph node radiation for patients with localized Hodgkin disease and unfavorable prognostic features: A phase II Cancer and Leukemia Group B Study (9051).
Wasserman TH, Petroni GR, Millard FE, Chung CT, Barcos M, Johnson JL, Canellos GP, Peterson BA. Wasserman TH, et al. Among authors: petroni gr. Cancer. 1999 Oct 15;86(8):1590-5. doi: 10.1002/(sici)1097-0142(19991015)86:8<1590::aid-cncr29>3.0.co;2-4. Cancer. 1999. PMID: 10526290 Clinical Trial.
Dose-escalated cyclophosphamide, doxorubicin, vincristine, prednisone, and etoposide (CHOPE) chemotherapy for patients with diffuse lymphoma: Cancer and Leukemia Group B studies 8852 and 8854.
Bartlett NL, Petroni GR, Parker BA, Wagner ND, Gockerman JP, Omura GA, Canellos GP, Robert M, Johnson JL, Peterson BA. Bartlett NL, et al. Among authors: petroni gr. Cancer. 2001 Jul 15;92(2):207-17. doi: 10.1002/1097-0142(20010715)92:2<207::aid-cncr1311>3.0.co;2-d. Cancer. 2001. PMID: 11466671 Clinical Trial.
Immunity to melanoma antigens: from self-tolerance to immunotherapy.
Slingluff CL Jr, Chianese-Bullock KA, Bullock TN, Grosh WW, Mullins DW, Nichols L, Olson W, Petroni G, Smolkin M, Engelhard VH. Slingluff CL Jr, et al. Adv Immunol. 2006;90:243-95. doi: 10.1016/S0065-2776(06)90007-8. Adv Immunol. 2006. PMID: 16730266 Review.
Clinical activity and safety of combination therapy with temsirolimus and bevacizumab for advanced melanoma: a phase II trial (CTEP 7190/Mel47).
Slingluff CL Jr, Petroni GR, Molhoek KR, Brautigan DL, Chianese-Bullock KA, Shada AL, Smolkin ME, Olson WC, Gaucher A, Chase CM, Grosh WW, Weiss GR, Wagenseller AG, Olszanski AJ, Martin L, Shea SM, Erdag G, Ram P, Gershenwald JE, Weber MJ. Slingluff CL Jr, et al. Among authors: petroni gr. Clin Cancer Res. 2013 Jul 1;19(13):3611-20. doi: 10.1158/1078-0432.CCR-12-3919. Epub 2013 Apr 25. Clin Cancer Res. 2013. PMID: 23620404 Free PMC article. Clinical Trial.
A randomized pilot trial testing the safety and immunologic effects of a MAGE-A3 protein plus AS15 immunostimulant administered into muscle or into dermal/subcutaneous sites.
Slingluff CL Jr, Petroni GR, Olson WC, Smolkin ME, Chianese-Bullock KA, Mauldin IS, Smith KT, Deacon DH, Varhegyi NE, Donnelly SB, Reed CM, Scott K, Galeassi NV, Grosh WW. Slingluff CL Jr, et al. Among authors: petroni gr. Cancer Immunol Immunother. 2016 Jan;65(1):25-36. doi: 10.1007/s00262-015-1770-9. Epub 2015 Nov 18. Cancer Immunol Immunother. 2016. PMID: 26581199 Free PMC article. Clinical Trial.
A Novel Form of Breast Intraoperative Radiation Therapy With CT-Guided High-Dose-Rate Brachytherapy: Results of a Prospective Phase 1 Clinical Trial.
Showalter SL, Petroni G, Trifiletti DM, Libby B, Schroen AT, Brenin DR, Dalal P, Smolkin M, Reardon KA, Showalter TN. Showalter SL, et al. Int J Radiat Oncol Biol Phys. 2016 Sep 1;96(1):46-54. doi: 10.1016/j.ijrobp.2016.04.035. Epub 2016 May 7. Int J Radiat Oncol Biol Phys. 2016. PMID: 27511846 Clinical Trial.
136 results